(Q34550827)
Statements
1 reference
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate (English)
1 reference
Caio M Rocha Lima
1 reference
Mark R Green
1 reference
Robert Rotche
1 reference
Wilson H Miller
1 reference
G Mark Jeffrey
1 reference
Laura A Cisar
1 reference
Adele Morganti
1 reference
Nicoletta Orlando
1 reference
Gabriela Gruia
1 reference
Langdon L Miller
1 reference
1 September 2004
1 reference
1 reference
Identifiers
1 reference